Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making a little go a long way...

Stella M Davies1

  • 1CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER.

Blood
|May 9, 2015
PubMed
Summary

Enforced fucosylation is a safe strategy to improve engraftment after unrelated cord blood transplantation. Modified cord blood units led to faster platelet and neutrophil engraftment in adults compared to historical controls.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapy.

Blood reviews·2026
Same author

Blood proteomics of paediatric bronchiolitis obliterans syndrome after haematopoietic cell transplant.

ERJ open research·2026
Same author

TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study.

Blood advances·2026
Same author

The gut virome in children undergoing hematopoietic cell transplantation is diverse and a site for viral reactivation.

Bone marrow transplantation·2026
Same author

Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

Transplantation and cellular therapy·2026
Same author

Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders.

Blood advances·2026

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Cellular Therapy

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a critical treatment for hematologic malignancies and other diseases.
  • Unrelated cord blood (UCB) transplantation is a vital source of stem cells, but engraftment can be delayed.
  • Improving engraftment kinetics is crucial for reducing complications and improving patient outcomes.

Purpose of the Study:

  • To evaluate the safety and feasibility of a novel strategy called enforced fucosylation.
  • To determine if enforced fucosylation can enhance engraftment after UCB transplantation in adult recipients.
  • To compare engraftment times of platelets and neutrophils with historical controls.

Main Methods:

  • A clinical trial was conducted to test the enforced fucosylation strategy.
  • Adult patients received UCB units modified with enforced fucosylation.
  • Engraftment of platelets and neutrophils was monitored and compared to historical data.

Main Results:

  • The enforced fucosylation strategy was demonstrated to be safe in adult recipients.
  • Patients receiving modified UCB units showed accelerated engraftment of both platelets and neutrophils.
  • Engraftment times were significantly faster compared to historical control groups.

Conclusions:

  • Enforced fucosylation is a safe and feasible approach to improve UCB transplantation outcomes.
  • This novel strategy accelerates key hematologic recovery markers post-transplant.
  • Further investigation into enforced fucosylation may optimize UCB transplantation protocols.

Related Experiment Videos